The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: A meta-analysis of outcome data

Journal of Parenteral and Enteral Nutrition

Volumn 32, Issue 6, 2008, Pages 596-605

  Pontes Arruda, Alessandro ^a   DeMichele, Stephen ^b   Seth, Anand ^b   Singer, Pierre ^c  

^a Fernandes Tavora Hospital   (Brazil)

^b ABBOTT LABORATORIES   (United States)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

linolenic acid; ALI; ARDS; Borage oil; Critical care; Eicosapentaenoic acid; Fish oil; Inflammation; Meta analysis; Omega 3 fatty acids; Sepsis

Indexed keywords

GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID;

ACUTE LUNG INJURY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; DIET THERAPY; HUMAN; INTENSIVE CARE UNIT; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SYSTEMATIC REVIEW;

ACUTE LUNG INJURY; CONFIDENCE INTERVALS; DIET; EICOSAPENTAENOIC ACID; ENTERAL NUTRITION; GAMMA-LINOLENIC ACID; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MULTIPLE ORGAN FAILURE; ODDS RATIO; PULMONARY GAS EXCHANGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

BORAGINACEAE;

EID: 54249108444     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108324203     Document Type: Article

References (41)

1. Weinacker AB, Vaszar LT Acute respiratory distress syndrome: physiology and new management strategies. Ann Rev Med. 2001 ; 52: 221-237.
2. Rubenfeld GD, Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005 ; 353: 1685-1693.
3. Jain R., DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc. 2006 ; 81: 205-212.
4. Heyland DK, Dhaliwal R., Drover JW, Gramlich L., Dodek P. ; Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guidelines for nutrition support in mechanically ventilated patients, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003 ; 27: 355-373.
5. Heyland DK, Dhaliwal R. Immunonutrition in the critically ill: from old approaches to new paradigms. Intensive Care Med. 2005 ; 31: 501-503.
6. Mancuso P., Whelan J., DeMichele SJ, Snider CC, Guszcza JA, Karlstad MD Dietary fish oil and borage oil suppress intrapulmonary proinflammatory eicosanoids biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxemic rats. Crit Care Med. 1997 ; 25: 1198-1206.
7. Mancuso P., Whelan J., DeMichele SJ, et al. Effects of eicosapentaenoic acid on lung permeability and alveolar macrophage eicosanoids synthesis in endotoxic rats. Crit Care Med. 1997 ; 25: 523-532.
8. Murray MJ, Kumar M., Gregory TJ, Banks PL, Tazelaar HD, DeMichele SJ Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. Am J Physiol. 1995 ; 269: H2090 - H2099.
9. Palombo JD, DeMichele SJ, Boyce PJ, et al. Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med. 1999 ; 27: 1908-1915.
10. Pacht ER, DeMichele SJ, Nelson JL, Hart J., Wennberg AK, Gadek JE Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med. 2003 ; 31: 491-500.
11. Gadek J., DeMichele S., Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med. 1999 ; 27: 1409-1420.
12. Singer P., Theilla M., Fisher H., Gibstein L., Grozovski E., Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006 ; 34: 1033-1038.
13. Pontes-Arruda A., Aragão AM, Albuquerque JD Effects of enteral feeding with eicosapentaenoic acid (EPA), gamma-linolenic acid and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006 ; 34: 2325-2333.
14. Heyland DK, MacDonald S., Keefe L., Drover JW Total parenteral nutrition in critically ill patients: a meta-analysis. JAMA. 1998 ; 280: 2013-2019.
15. Doig GS, Simpson F., Delaney A. A review of the true methodological quality of nutritional support trials conducted in the critically ill: time for improvement. Anesth Analg. 2005 ; 100: 527-533.
16. Schultz KF, Chalmers I., Hayes RJ, Altman DG Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995 ; 273: 408-412.
17. Huwiler-Muntener K., Juni P., Junker C., Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. 2002 ; 287: 2801-2804.
18. Egger M., Juni P., Bartlett C., Holenstein F., Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess. 2003 ; 7: 1-76.
19. Graf J., Doig GS, Cook DJ, Vincent JL, Sibbald WJ Randomized, controlled clinical trials in sepsis: has methodological quality improved over time ? Crit Care Med. 2002 ; 30: 461-472.
20. Lachin JM Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000 ; 21: 167-189.
21. Flather MD, Farkouth ME, Pogue JM, Yusuf S. Strengths and limitations of meta-analysis: larger studies may be more reliable. Control Clin Trials. 1997 ; 18: 568-579.
22. Haynes R., Wilczynski N., McKibbon A., Walker C., Sinclair J. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc. 1994 ; 1: 447-458.
23. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 ; 344: 699-709.
24. Borenstein M., Hedges L., Higgins J., Rothstein H. Introduction to Meta-Analysis. Chichester, UK: Wiley; 2008.
25. Mayer D. Meta-analysis and systematic reviews. In: Mayer D, ed. Essential Evidence-Based Medicine. Cambridge, UK: Cambridge University Press; 1994: 321-328.
26. Elamin M., Hughes LF, Drew D. Effect of enteral nutrition with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants reduced alveolar inflammatory mediators and proteins influx in patients with acute respiratory distress syndrome (ARDS). Chest. 2005 ; 128 (suppl): 225S.
27. Moran V., Grau T., García-de-Lorenzo A., et al. Effect of an enteral feeding with eicosapentaenoic and gamma-linolenic acids on the outcome of mechanically ventilated critically ill septic patients. Crit Care Med. 2006 ; 34: A70.
28. DeMichele SJ, Wood SM, Wennberg AK A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome. Respir Care Clin N Am. 2006 ; 12: 547-566.
29. Mizock BA Nutritional support in acute lung injury and acute respiratory distress syndrome. Nutr Clin Pract. 2001 ; 16: 319-328.
30. Mizock BA, DeMichele SJ The acute respiratory distress syndrome: role of nutritional modulation through dietary lipids. Nutr Clin Pract. 2004 ; 19: 563-574.
31. Nelson JL, DeMichele SJ, Pacht E., Wennberg AK; Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. JPEN J Parenter Enteral Nutr. 2003 ; 27: 98-104.
32. Denys A., Hichami A., Khan NA n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J Lipid Res. 2005 ; 46: 752-758.
33. Calder PC N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids. 2003 ; 38: 343-352.
34. Hasturk H., Kantarci A., Goguet-Surmenian E., et al. Resolvin E1 regulates inflammation on the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. 2007 ; 179: 7021-7029.
35. Bannenberg G., Arita M., Serhan CN Endogenous receptor agonists: resolving inflammation. ScientificWorldJournal. 2007 ; 7: 1440-1462.
36. Palombo JD, DeMichele SJ, Boyce PJ, Noursalehi M., Forse RA, Bistrian BR Metabolism of dietary alpha-linolenic acid vs eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia. Lipids. 1998 ; 33: 1099-1105.
37. Mayes T., Gottschlich M., Kagan R. An evaluation of the safety and efficacy of an anti-inflammatory, pulmonary enteral formula in the treatment of pediatric burn patients with respiratory failure. J Burn Care Res. 2008 ; 29: 82-88.
38. Nadkarni V., DeMichele S., Goldstein B., Checchia P., Ayad O., Jacobs B. ; The Nutritional Immunomodulation in Children with Lung Injury (NICLI) Study Group. Safety of an enteral formula enriched with eicosapentaenoic and gamma-linolenic acids in critically ill children with acute lung injury. Crit Care Med. 2005 ; 33: 172M.
39. Angus DC, Linde-Zwirble WT, Lidicker J., Clermont G., Carcillo J., Pinsky MR Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 ; 29: 1303-1310.
40. Salipante DM Developing a multidisciplinary weaning unit through collaboration. Crit Care Nurse. 2002 ; 22: 30-39.
41. Teres D., Rapoport J., Lemeshow S., Kim S., Akhras. Cost of care associated with early sepsis (first 24 hours of ICU admission) in a United States medical center. Crit Care. 2001 ; 5 (suppl 1). P258.